Correlation Between Iovance Biotherapeutics and Monopar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Monopar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Monopar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Monopar Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Monopar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Monopar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Monopar Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Monopar Therapeutics
-0.24 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Iovance and Monopar is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Monopar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monopar Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Monopar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monopar Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Monopar Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Monopar Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 11.38 times less return on investment than Monopar Therapeutics. But when comparing it to its historical volatility, Iovance Biotherapeutics is 6.92 times less risky than Monopar Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Monopar Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 145.00 in Monopar Therapeutics on September 14, 2024 and sell it today you would earn a total of 2,393 from holding Monopar Therapeutics or generate 1650.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Monopar Therapeutics
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Monopar Therapeutics |
Iovance Biotherapeutics and Monopar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Monopar Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Monopar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Monopar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monopar Therapeutics will offset losses from the drop in Monopar Therapeutics' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Monopar Therapeutics vs. Puma Biotechnology | Monopar Therapeutics vs. Iovance Biotherapeutics | Monopar Therapeutics vs. Day One Biopharmaceuticals | Monopar Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |